Metastatic pancreatic endocrine carcinoma

Also known as: Pancreatic Carcinoma Metastatic / Metastatic Pancreatic Carcinoma / Pancreatic carcinoma stage IV

DrugDrug NameDrug Description
DB01101CapecitabineA nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer.
DrugDrug NamePhaseStatusCount
DB11794Berzosertib1Active Not Recruiting1
DB04690Camptothecin1Active Not Recruiting1
DB01101Capecitabine1Completed1
DB00530Erlotinib1Completed1
DB00441Gemcitabine1Completed1
DB01611Hydroxychloroquine1Recruiting1
DB00762Irinotecan1Active Not Recruiting1
DB11793Niraparib1Recruiting1
DB08911Trametinib1Recruiting1
DB11841Entinostat1 / 2Recruiting1
DB00441Gemcitabine1 / 2Completed1
DB00480Lenalidomide1 / 2Completed1
DB00085Pancrelipase1 / 2Recruiting1
DB11065Pancrelipase amylase1 / 2Recruiting1
DB13147Pancrelipase lipase1 / 2Recruiting1
DB11066Pancrelipase protease1 / 2Recruiting1
DB11967Binimetinib2Active Not Recruiting1
DB14547Chloride ion2Not Yet Recruiting1
DB00515Cisplatin2Not Yet Recruiting1
DB12109Devimistat2Recruiting1
DB01248Docetaxel2Completed1
DB11718Encorafenib2Active Not Recruiting1
DB00544Fluorouracil2Recruiting1
DB00317Gefitinib2Completed1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Recruiting2
DB01611Hydroxychloroquine2Recruiting1
DB00166Lipoic acid2Recruiting1
DB01229Paclitaxel2Completed1
DB12257Platinum2Not Yet Recruiting1
DB11760Talazoparib2Recruiting1
DB17448Tusamitamab ravtansine2Recruiting1
DB00460Verteporfin2Recruiting1